Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Single-day hybridization-based capture with KAPA Target Enrichment probes (NGS) Mariana Fitarelli Kiehl, PhD, Sr. Applications Scientist at Roche Sequencing & Life Science Providing targeted next-generation sequencing (NGS) results faster is a common challenge facing labs today. By reducing the time required for hybridiz... 12 months ago | 18 mins Work/Life Integration Means More Work for InfoSec: Tech Hybridization & Risk Bob Delfin, Senior Sales Engineer As we continue to adjust to the new normal, facing a new wave of changes to the way we work, security teams are faced with a new challenge of absorbin... 11 months ago | 23 mins Work/Life Integration Means More Work for InfoSec: Tech Hybridization & Risk Bob Delfin, Senior Sales Engineer As we continue to adjust to the new normal, facing a new wave of changes to the way we work, security teams are faced with a new challenge of absorbin... 11 months ago | 23 mins Work/Life Integration Means More Work for InfoSec: Tech Hybridization & Risk Bob Delfin, Senior Sales Engineer As we continue to adjust to the new normal, facing a new wave of changes to the way we work, security teams are faced with a new challenge of absorbin... 1 year ago | 23 mins Target Enriched RNA-seq for SARS-CoV-2 Surveillance and Genome Analysis Sarah Trusiak, PhD, Sr. Application Scientist, Roche Sequencing and Life Science New SARS-CoV-2 strains are continuing to emerge, potentially impacting the effectiveness of existing vaccines. Thus, the ability to determine the geno... 7 months ago | 31 mins Battle of the ALKs: ALK IHC vs. ISH in treatment of ALK-positive advanced NSCLC Prof Dr EMD (Ed) Schuuring & Prof Dr HJM (Harry) Groen Join Dr. Ed Schuuring and Dr. Harry Groen, University Medical Center Groningen, The Netherlands, to explore the role of immunohistochemistry (IHC) in ... 4 years ago | 56 mins ROS1 in NSCLC Pathology and Prediction Dr. Erik Thunnissen, FBJM ROS1 in NSCLC Pathology and Prediction presented by Dr. Erik Thunnissen, FBJM, Department of Pathology, VU University Medical Center Amsterdam, The Ne... 4 years ago | 12 mins The Dangers of Using a Laboratory-Developed Test as a Companion Diagnostic Keith Miller, FIBMS The Dangers of Using a Laboratory-Developed Test as a Companion Diagnostic presented by Keith Miller, FIBMS, Director, UK National External Quality As... 4 years ago | 25 mins Modern Strategies for SQL Server Disaster Recovery Sumeet Bansal Microsoft has done an amazing job of evolving the SQL Server platform. Looking back from SQL Server 7.0 and SQL Server 2000 to the current crop of SQL... 6 years ago | 60 mins ALK IHC vs ISH and ALK Inhibitors in Treatment of ALK-Positive Advanced NSCLC Prof Dr EMD (Ed) Schuuring and Prof Dr HJM (Harry) Groen ALK IHC vs ISH and ALK Inhibitors in Treatment of ALK-Positive Advanced NSCLC presented by Prof Dr. EMD (Ed) Schuuring, Clinical Scientist in Molecula... 4 years ago | 32 mins
